Work

Inhibition of tumor growth in a VEGFR TKI-resistant model of renal cell carcinoma using dalantercept combined with sunitinib.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.370

Authors: Rupal Satish Bhatt, Xiaoen Wang, Nicolas Solban, Lin Wei, Sabina Signoretti, David Alsop, Marat Alimzhanov, Scott Pearsall, Michael B. Atkins, Ravi Kumar, Matthew L. Sherman, James Walter Mier

Institutions: Beth Israel Deaconess Medical Center, Acceleron Pharma (United States), Brigham and Women's Hospital, Harvard University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590488340

Cites:

Cited by: 1

Related to: 10